Approval · Notice of Compliance 7216 · 2005
ANGELIQ: Notice of Compliance 7216
Issued July 8, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7216
- Date
- July 8, 2005
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Hormone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANGELIQ | 02268825 | Marketed |
Medicinal ingredients
- ESTRADIOL 1 MG per TAB
- DROSPIRENONE 1 MG per TAB